Delivery Order SPE2DB24D1104-SPE2DB25FXTV3

Award Date 10/28/24
Potential Completion Date 10/29/24
Potential Value $30K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fingolimod 0.5 mg capsules, a specialty medication used in the treatment of certain medical conditions. The contract is a firm fixed-price, delivery order with a ceiling value of $27,491.97 and a completion date of November 14, 2024. This contract award is not designated...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S. The contract has a firm fixed price of $40,665.30 and a period of performance through December 12, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply Fingolimod 0.5 mg capsules. The contract has a firm-fixed price of $2,823.25 and a period of performance through July 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,906.06, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of January 28, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Fingolimod 0.5 mg capsules. The contract has a firm fixed price of $13,261.27 and an ultimate completion date of August 5, 2024. It is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $40,485.98, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication, with a completion date of November 13, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a Delivery Order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $13,924.07, is for the supply of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This contract is a delivery order award to AmerisourceBergen Drug Corp., a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $41,662.23, is for the delivery of the drug fingolimod 0.5 mg capsules. The contract has an ultimate completion date of September 4, 2024 and is a firm fixed price contract. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $51,412.21 contract is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a prescription medication, to support DLA Troop Support Medical facilities. No set-aside designation was used. AmerisourceBergen Drug Corp is an experienced federal contractor, having provided a range of...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $35,350.47 and is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication, to support military healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXTV3
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $30,035.71, is for the delivery of FINGOLIMOD 0.5 MG CAPSULE 30S, a specialty medication. The contract has an ultimate completion date of October 29, 2024 and uses a Firm Fixed Price pricing type. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this contract award.

Generated 2/2/25, 12:04 AM